2526 - 2550 of 6557 Results
Title
Year
-
OPENTitle: The glucocerebrosidase mutations and uric acid levels in Parkinson’s disease: A 3-years investigation of a potential biomarker”Journal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 8Issue #:Start Page: 100177End Page: 100177Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.prdoa.2022.100177Best OA location URL: https://doi.org/10.1016/j.prdoa.2022.100177Citation Count: 3
-
OPENTitle: Cognitive processes that indirectly affect olfactory dysfunction in Parkinson's diseaseJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 1Issue #:Start Page: 13End Page: 20Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.prdoa.2019.07.003Best OA location URL: https://doi.org/10.1016/j.prdoa.2019.07.003Citation Count: 7
-
OPENTitle: Distinct atrophy of septal nuclei in Parkinson’s diseaseJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 7Issue #:Start Page: 100171End Page: 100171Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2022.100171Best OA location URL: https://doi.org/10.1016/j.prdoa.2022.100171Citation Count: 1
-
OPENTitle: Synergistic associations of depressive symptoms and aging on cognitive decline in early Parkinson’s diseaseJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 8Issue #:Start Page: 100192End Page: 100192Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.prdoa.2023.100192Best OA location URL: https://doi.org/10.1016/j.prdoa.2023.100192Citation Count: 6
-
OPENTitle: Metabolic network expression in parkinsonism: Clinical and dopaminergic correlationsJournal Name: Journal of Cerebral Blood Flow & MetabolismPublisher: SAGE PublicationsVol: 37Issue #: 2Start Page: 683End Page: 693Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1177/0271678x16637880Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/0271678X16637880Citation Count: 63
-
OPENTitle: Heterogeneity of Cholinergic Denervation in Parkinson's Disease without DementiaJournal Name: Journal of Cerebral Blood Flow & MetabolismPublisher: SAGE PublicationsVol: 32Issue #: 8Start Page: 1609End Page: 1617Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/jcbfm.2012.60Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1038/jcbfm.2012.60Citation Count: 186
-
OPENTitle: Stem cells in development of therapeutics for Parkinson's disease: A perspectiveJournal Name: Journal of Cellular BiochemistryPublisher: WileyVol: 105Issue #: 5Start Page: 1153End Page: 1160Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/jcb.21916Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jcb.21916Citation Count: 15
-
OPENTitle: Hsp104 antagonizes α-synuclein aggregation and reduces dopaminergic degeneration in a rat model of Parkinson diseaseJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 118Issue #: 9Start Page: 3087End Page: 3097Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1172/jci35781Best OA location URL: http://www.jci.org/articles/view/35781/files/pdfCitation Count: 196
- Parkin, PINK1, and DJ-1 form a ubiquitin E3 ligase complex promoting unfolded protein degradation2009OPENTitle: Parkin, PINK1, and DJ-1 form a ubiquitin E3 ligase complex promoting unfolded protein degradationJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 119Issue #: 3Start Page: 650End Page: 660Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1172/jci37617Best OA location URL: http://doi.org/10.1172/JCI37617Citation Count: 389
-
OPENTitle: Wnt5a-treated midbrain neural stem cells improve dopamine cell replacement therapy in parkinsonian miceJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 118Issue #: 1Start Page: 149End Page: 160Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1172/jci32273Best OA location URL: http://doi.org/10.1172/JCI32273Citation Count: 178
- Direct regulation of complex I by mitochondrial MEF2D is disrupted in a mouse model of Parkinson disease and in human patients2011OPENTitle: Direct regulation of complex I by mitochondrial MEF2D is disrupted in a mouse model of Parkinson disease and in human patientsJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 121Issue #: 3Start Page: 930End Page: 940Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1172/jci43871Citation Count: 160
-
OPENTitle: α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cellsJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 121Issue #: 2Start Page: 715End Page: 725Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1172/jci43366Best OA location URL: https://resolver.sub.uni-goettingen.de/purl?gs-1/7841Citation Count: 838
-
OPENTitle: Widespread sex differences in gene expression and splicing in the adult human brainJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page: 2771End Page: 2771Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/ncomms3771Best OA location URL: https://kclpure.kcl.ac.uk/portal/en/publications/75c8359f-d7e0-4c9d-8d86-c004995b7417Citation Count: 338
-
OPENTitle: Genetic variability in the regulation of gene expression in ten regions of the human brainJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 17Issue #: 10Start Page: 1418End Page: 1428Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/nn.3801Best OA location URL: http://doi.org/10.1038/nn.3801Citation Count: 711
- Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease2010OPENTitle: Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson diseaseJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 120Issue #: 8Start Page: 2745End Page: 2754Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1172/jci42642Best OA location URL: http://www.jci.org/articles/view/42642/files/pdfCitation Count: 420
-
OPENTitle: Comprehensive characterization and optimization of anti-LRRK2 (leucine-rich repeat kinase 2) monoclonal antibodiesJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 453Issue #: 1Start Page: 101End Page: 113Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1042/bj20121742Best OA location URL: https://portlandpress.com/biochemj/article-pdf/453/1/101/675176/bj4530101.pdfCitation Count: 95
-
OPENTitle: The parkin-coregulated gene product PACRG promotes TNF signaling by stabilizing LUBACJournal Name: Science SignalingPublisher: American Association for the Advancement of Science (AAAS)Vol: 13Issue #: 617Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scisignal.aav1256Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7279956Citation Count: 25
-
OPENTitle: The Presence of Select Tau Species in Human Peripheral Tissues and Their Relation to Alzheimer’s DiseaseJournal Name: Journal of Alzheimer's DiseasePublisher: SAGE PublicationsVol: 51Issue #: 2Start Page: 345End Page: 356Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jad-150859Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6074044Citation Count: 96
-
OPENTitle: Selective loss of glucocerebrosidase activity in sporadic Parkinson’s disease and dementia with Lewy bodiesJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page: 15End Page: 15Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1186/s13024-015-0010-2Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s13024-015-0010-2Citation Count: 148
-
OPENTitle: Select E2 enzymes differentially regulate parkin activation and mitophagyJournal Name: Journal of Cell SciencePublisher: The Company of BiologistsVol:Issue #:Start Page: 3488End Page: 504Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1242/jcs.147520Best OA location URL: http://doi.org/10.1242/jcs.147520Citation Count: 70
-
OPENTitle: Myelin Basic Protein-primed T Cells Induce Neurotrophins in Glial Cells via α5β3 IntegrinJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 282Issue #: 44Start Page: 32222End Page: 32232Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1074/jbc.m702899200Best OA location URL: https://doi.org/10.1074/jbc.m702899200Citation Count: 37
- Cerebral Amyloid Deposition Is Associated with Gait Parameters in the Mayo Clinic Study of Aging2016OPENTitle: Cerebral Amyloid Deposition Is Associated with Gait Parameters in the Mayo Clinic Study of AgingJournal Name: Journal of the American Geriatrics SocietyPublisher: WileyVol: 65Issue #: 4Start Page: 792End Page: 799Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jgs.14670Best OA location URL: http://doi.org/10.1111/jgs.14670Citation Count: 63
-
OPENTitle: Deep Brain Stimulation Targeting the Fornix for Mild Alzheimer Dementia (the ADvance Trial): A Two Year Follow-up Including Results of Delayed ActivationJournal Name: Journal of Alzheimer's DiseasePublisher: SAGE PublicationsVol: 64Issue #: 2Start Page: 597End Page: 606Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jad-180121Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6518401Citation Count: 101
-
OPENTitle: Neuroimmunology of the Interleukins 13 and 4Journal Name: Brain SciencesPublisher: MDPI AGVol: 6Issue #: 2Start Page: 18End Page: 18Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/brainsci6020018Best OA location URL: https://www.mdpi.com/2076-3425/6/2/18/pdf?version=1465804812Citation Count: 126
-
OPENTitle: Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 35Issue #: 10Start Page: 2329End Page: 2346Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.03.032Best OA location URL: http://doi.org/10.1016/j.neurobiolaging.2014.03.032Citation Count: 70